Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Tokyo  >  Mitsubishi Tanabe Pharma Corp    4508   JP3469000008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures and distributes pharmaceuticals, pet products and medicines

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products.

Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera.

The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.

Number of employees : 8 457 persons.
Sales per Businesses
20142015Delta
JPY (in Million)%JPY (in Million)%
Pharmaceuticals412,675100%415,124100% +0.59%
Sales per Regions
20142015Delta
JPY (in Million)%JPY (in Million)%
Japan353,30085.6%337,18081.2% -4.78%
Europe37,3489.1%48,61811.7% +23.18%
Asia15,9773.9%17,2454.2% +7.35%
North America5,6271.4%11,6962.8% +51.89%
Other423.000.1%385.000.1% -9.87%
Managers
NameAgeSinceTitle
Masayuki Mitsuka, PhD612007President & Representative Director
Michihiro Tsuchiya, PhD681976Chairman
Eizou Tabaru--Manager-Finance & Investor Relations Contact
Minoru Muramatsu--Head-Information Systems, Public Relations & Legal
Kenkichi Kosakai622007Director
Kouji Nakamura--Director
Yoshiaki Ishizaki--Director & Chief Compliance Officer
Takashi Kobayashi601980Director & Managing Executive Officer
Shigehiko Hattori742011Independent Director
Shigetaka Sato742013Independent Director
Shareholders
NameShares%
Mitsubishi Chemical Holdings Corp. 316,320,000 56.3%
Nippon Life Insurance Co. 12,065,000 2.15%
Mitsubishi UFJ Financial Group, Inc. 9,372,113 1.67%
Mitsubishi Tanabe Pharma Employee Stock Ownership Plan 4,505,000 0.80%
BlackRock Fund Advisors 3,821,500 0.68%
Nipro Corp. 3,821,000 0.68%
The Vanguard Group, Inc. 3,438,806 0.61%
Tokio Marine Holdings, Inc. 3,132,900 0.56%
Wellington Management Co. LLP 2,734,400 0.49%
Norges Bank Investment Management 2,720,679 0.48%
Holdings
NameShares%Valuation
SUZUKEN CO., LTD. (9987) 1,548,1921.50%50,589,620 USD
Alfresa Holdings Corporation (2784) 2,225,8120.95%34,168,752 USD
Medipal Holdings Corp (7459) 2,123,6360.87%32,993,828 USD
VITAL KSK HOLDINGS INC (3151) 2,655,2964.34%18,786,830 USD
T&D Holdings Inc (8795) 1,144,8800.17%17,169,285 USD
Nippon Shinyaku Co., Ltd. (4516) 519,0000.74%15,871,752 USD
Mitsubishi Tanabe Pharma Corp (4508) 428,3000.076%6,813,041 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 250,0000.41%5,802,008 USD
Iyo Bank Ltd (8385) 291,5660.090%3,573,649 USD
TSURUHA HOLDINGS INC. (3391) 40,0000.082%3,013,820 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
ALLERGAN PLC
BAYER AG
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
GLAXOSMITHKLINE P..
ELI LILLY AND CO
VALEANT PHARMACEU..
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
REGENERON PHARMAC..
SHIRE PLC
TAKEDA PHARMACEUT..
MYLAN NV
ASTELLAS PHARMA I..
Sector Pharmaceuticals
Mitsubishi Tanabe Pharma C : Connections
Mitsubishi Tanabe Pharma Factory Ltd.
The Kaiteki Institute, Inc.
The Osaka Chamber of Commerce & Industry
Meiji Yasuda Life Insurance Co.
Company contact information
Mitsubishi Tanabe Pharma Corp.
3-2-10 Dosho-machi
Chuo-Ku
Osaka 541-8505

Phone : +81.6.6205.5085
Fax : +81.6.6205.5262
Web : www.mt-pharma.co.jp
© 2015 People , Fundamentals and Ownership